Global Aseptic Sampling Market

Global Aseptic Sampling Market Size, Share, Growth Analysis, By Type(Manual Aseptic Sampling, and Automated Aseptic Sampling), By Technique(Off-Line Sampling Technique, At-Line Sampling Technique), By Application(Upstream Processes, and Downstream Processes), By End User(Biotechnology and Pharmaceutical Manufacturers, Contract Research and Manufacturing Organizations) - Industry Forecast 2024-2031


Report ID: SQMIG35D2078 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 116 | Figures: 71

Global Aseptic Sampling Market Insights

Global Aseptic Sampling Market size was valued at USD 333.53 million in 2022 and is poised to grow from USD 374.89 million in 2023 to USD 955.06 million by 2031, at a CAGR of 12.40% during the forecast period (2024-2031).

The surge in the demand for biopharmaceuticals, which resulted in an increase in the use of single-use aseptic sampling products, is one of the main drivers supporting the aseptic sampling market growth. The United States spent over USD 3.65 trillion on national health care, according to the Centres for Disease Control and Prevention.

The increase in government regulations to guarantee drug safety and quality, as well as R&D activity in the sector and rise in government spending on healthcare, are additional factors anticipated to support market expansion.

Products in aseptic sampling are made of processed plastic polymers that can leach and extract from solvents, which might cause contamination. One of the main factors impeding the expansion of the global aseptic sampling market is concerns about leachable and extractability from single-use items. On the other hand, a number of biopharmaceutical procedures usually call for high temperatures in order to function, which causes the production of superfluous and unidentified compounds that could contaminate the final product. This is yet another important factor that restricts the use of single-use bioprocessing systems.

US Aseptic Sampling Market is poised to grow at sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Aseptic Sampling Market size was valued at USD 333.53 million in 2022 and is poised to grow from USD 374.89 million in 2023 to USD 955.06 million by 2031, at a CAGR of 12.40% during the forecast period (2024-2031).

The competitive landscape for the aseptic sampling market gives information by competitor. Included information includes a business overview, financials, revenue generated, market potential, investments in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launches, product breadth and depth, and application dominance. Only the companies' focus on the aseptic sample market is mentioned in the data points above. 'QualiTru Sampling Systems (U.S.)', 'Gemü Group (U.S.)', 'Flownamics (U.S.)', 'Sartorius AG (Germany)', 'Merck KGaA (Germany)', 'Danaher (U.S.)', 'Thermo Fisher Scientific Inc. (U.S.)', 'Saint-Gobain (France)', 'GEA Group Aktiengesellschaft (Germany)', 'Avantor, Inc. (U.S.)', 'Keofitt A/S (Denmark)', 'W. L. Gore & Associates (U.S.)', 'Lonza (Switzerland)', 'Trace Analytics (U.S.)'

Aseptic sampling market growth will be largely driven by factors such as increasing R&D activities, increasing healthcare infrastructure investments in developing countries, rising pharmaceutical demand, expanding government regulations to ensure drug safety and quality, and rising biotechnology-based company establishment.

The aseptic sample market is expected to increase significantly for biotechnology and pharmaceutical firms because of rising R&D spending and a growing pipeline of biological and pharmaceutical products. For instance, one of the biopharmaceutical businesses, Amgen Inc., has seen a growth in its research and development spending throughout the years. According to Amgen Inc.'s 2022 annual report, this spending went from USD 4,207 million in 2021 to USD 4,819 million in 2022. Growth in the market is also anticipated to be fuelled by improvements in product technology and their adoption by pharma and biotech firms.

During the forecast period, North America is anticipated to maintain its significant market share in aseptic sampling. The North American aseptic sample market will also be driven by an increase in product launches and expansions by major industry participants and strict government regulations regarding the safety and quality of various pharmaceuticals. Due to the existence of major market participants and the growing assistance provided by the government for the manufacture and high calibre of pharmaceutical and biotech products, the United States is anticipated to hold a sizable proportion of the market. A number of methods have been implemented by major players in the area to maintain market share and grow into additional product categories.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Aseptic Sampling Market

Product ID: SQMIG35D2078

$5,300
BUY NOW GET FREE SAMPLE